Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

TOBRADEX ST

(TOBRAMYCIN / DEXAMETHASONE)standard

Harrow Eye, LLC

Corticosteroid [EPC]

12.1 Mechanism of Action Dexamethasone is a potent corticoid. Corticoids suppress the inflammatory response to a variety of agents and they can delay ...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis.
Search all trials →

Search clinical trials for Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis →